ARTICLE | Company News
Athera cardiovascular news
June 24, 2013 7:00 AM UTC
Athera received a grant from the EU's Seventh Framework Program (FP7) to develop the company's human antibody PC-mAb to treat patients with an increased risk of atherosclerosis-related cardiovascular...